BRIEF published on 01/26/2026 at 17:50, 2 months 21 days ago Gimv Shifts Focus, Ends New Life Sciences Investments Portfolio Management Investment Strategy Gimv Life Sciences Digital Transition
REGULATED PRESS RELEASE published on 01/26/2026 at 17:45, 2 months 21 days ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments Gimv focuses on strategic objectives, discontinues new Life Sciences investments to concentrate on Consumer, Healthcare, Smart Industries, Sustainable Cities Gimv Healthcare Investments Strategic Objectives Consumer
BRIEF published on 01/20/2026 at 07:35, 2 months 27 days ago Gimv Leads €51 Million Investment in Exciva for Alzheimer's Therapy Series B Funding Gimv Investment Exciva GmbH Alzheimer’s Therapy Deraphan Trial
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 2 months 27 days ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy Exciva secures €51m funding led by Gimv and EQT for Alzheimer's therapy. Deraphan targets agitation in Phase II trial, promising improved care for patients Funding Phase II Trial Exciva Alzheimer's Therapy Deraphan
BRIEF published on 01/16/2026 at 07:35, 3 months ago Gimv Sells Majority Stake in ALT Technologies to CCL Industries Acquisition Automotive Industry Gimv CCL Industries ALT Technologies
REGULATED PRESS RELEASE published on 01/16/2026 at 07:30, 3 months ago Gimv sells majority stake in ALT Technologies to CCL Industries Gimv sells majority stake in ALT Technologies to CCL Industries, enhancing CCL's capabilities in automotive industry; transaction subject to closing conditions Automotive Industry Gimv Transaction CCL Industries ALT Technologies
BRIEF published on 11/27/2025 at 07:35, 4 months 19 days ago Gimv and CNP Partner to Propel Equine Care Group's Global Growth Global Expansion Gimv Equine Care Group CNP Equine Healthcare
REGULATED PRESS RELEASE published on 11/27/2025 at 07:30, 4 months 19 days ago Gimv joins forces with CNP to accelerate the global expansion of Equine Care Group Gimv partners with CNP to boost Equine Care Group's global expansion, aiming to lead in equine medicine innovation and excellence with minority stake acquisition Global Expansion Gimv Equine Care Group CNP Equine Medicine
REGULATED PRESS RELEASE published on 11/20/2025 at 07:00, 4 months 26 days ago Solid growth performance in the first half of FY 2025
BRIEF published on 11/05/2025 at 07:35, 5 months 11 days ago Gimv Invests in Quality Guard for European Food Safety Compliance SaaS Platform European Expansion Gimv Investment Quality Guard Food Safety Compliance
Published on 04/17/2026 at 02:13, 2 hours 40 minutes ago CHAR Tech annonce l’acquisition projetée d’actifs de biocarbone au Québec, incluant un accord d’achat de 62 500 tonnes, une installation et de la propriété intellectuelle
Published on 04/17/2026 at 02:00, 2 hours 53 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 5 hours 21 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 7 hours 23 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 23:40, 5 hours 13 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 7 hours 16 minutes ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 7 hours 53 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 8 hours 18 minutes ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 9 hours 35 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 10 hours 51 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 10 hours 59 minutes ago Aéroports de Paris S.A - March 2026 traffic figures
